Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Premarin

Premarin
In stock
0,625mg
from A$187.03
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$224.44A$187.03
A$6.68 per tablet

In brief

  • In our pharmacy, you can buy premarin without a prescription, with delivery available across Australia and discreet packaging on request.
  • Premarin (conjugated estrogens) is used for hormone replacement therapy to relieve vasomotor and urogenital symptoms of menopause, for prevention of postmenopausal osteoporosis and for hypoestrogenism; it works by replacing oestrogen and activating oestrogen receptors in target tissues.
  • The usual dose for menopausal symptoms is 0.3–1.25 mg daily (most commonly starting at 0.3 or 0.625 mg); 0.625 mg daily is commonly used for osteoporosis prevention, with doses individualised as needed.
  • Administered orally as tablets (common strengths 0.3, 0.625, 0.9 and 1.25 mg); injectable formulations are used only for short-term hospital care.
  • Patients may begin to notice symptom improvement within 1–2 weeks, with more substantial benefit often seen by 4–8 weeks.
  • Premarin is taken once daily and therapeutic effects are maintained with continuous use; a single dose has pharmacological activity for about 24 hours, so daily dosing is standard.
  • Avoid excessive alcohol while taking premarin; alcohol can worsen side effects, affect liver function and may increase risks such as bleeding or thromboembolism, so use with caution.
  • The most common side effect is headache (other frequent effects include breast tenderness, nausea, vaginal spotting and fluid retention).
  • Would you like to try premarin without a prescription?

Critical Warnings And Restrictions

Basic Premarin Information

  • INN (International Nonproprietary Name): Conjugated estrogens.
  • Brand Names Available In Australia: Premarin (Pfizer) — commonly in 0.625 mg and 1.25 mg tablets, blister 28s.
  • ATC Code: G03CA57.
  • Forms & Dosages: Tablets 0.3 mg, 0.625 mg, 0.9 mg, 1.25 mg; injection (IV) for short‑term hospital use.
  • Manufacturers In Australia: Global manufacturer Pfizer; local supply via Pfizer affiliates or national distributors.
  • Registration Status In Australia: TGA registered; prescription‑only medicine.
  • OTC / Rx Classification: Prescription only (Rx).

High‑Risk Groups

People ask, “Who should be most careful with Premarin?”.

The absolute contraindications are critical to screen for before supply or counselling.

  • Absolute Contraindications:
  • Undiagnosed vaginal bleeding.
  • Known, suspected or history of breast, uterine or oestrogen‑dependent cancer.
  • Active or history of deep vein thrombosis (DVT) or pulmonary embolism (PE).
  • Recent or history of stroke or myocardial infarction.
  • Severe liver dysfunction.
  • Pregnancy or breastfeeding.

Elderly patients need the lowest effective dose because of increased risk of stroke and venous thromboembolism.

Patients with diabetes, hypertension, obesity or a smoking history require baseline cardiovascular and thrombotic risk assessment.

For palliative oncology use, specialist supervision and documented protocols are essential.

Pharmacists should use a screening checklist at supply to reduce harm.

  • Supply Checklist:
  • Confirm contraindications and unexplained vaginal bleeding.
  • Ask about current HRT or oestrogen use and previous VTE.
  • Document smoking status, blood pressure and recent liver function results if available.
  • Refer to the prescriber if any red flags or insufficient information exist.

Interaction With Activities

Many patients want to know whether Premarin affects driving or work safety.

Report any dizziness, sudden visual changes, fainting or excessive sleepiness immediately.

  • Fitness To Drive: If you experience dizziness, sudden visual changes, severe headache, fainting or somnolence after starting or changing dose, do not drive.
  • Fitness For Work: For safety‑critical roles (heavy machinery, shift work), avoid duties until you know how Premarin affects you and consider temporary leave during dose initiation.

Australian road and workplace safety laws require fitness for duty and fitness to drive; clinicians and pharmacists should document counselling in clinical notes.

Alcohol can worsen sedation and may increase vascular risk; advise moderation or avoidance around dose changes.

Employers may request medical clearance for safety‑critical tasks — document and refer to the prescriber as needed.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: Usually yes, if you feel well and have not had any adverse effects after starting or adjusting Premarin.

If you notice dizziness, a sudden change in vision, a severe headache, fainting, or excessive sleepiness after starting or changing the dose, do not drive and seek medical advice immediately.

Document any counselling you give about fitness to drive or operate machinery in pharmacy or clinical notes.

If you work nights, use heavy machinery or have a safety‑critical role, speak with your prescriber about whether you should take time off during the first few days of treatment or until you know how Premarin affects you.

Carry a current medicine list and your prescriber’s contact details while driving for longer trips.

Usage Basics

INN And Brand Names Available In Australia

What is Premarin and how is it presented locally?

Premarin’s INN is conjugated estrogens and it is classified under ATC code G03CA57.

In Australia Premarin is marketed by Pfizer and is most commonly supplied as 0.625 mg and 1.25 mg tablets in blister packs of 28.

When counselling, confirm the exact pack size and strength on the prescription.

Alternative conjugated oestrogen products exist internationally, so always verify TGA‑approved listings for local availability.

Formulation Strength Local Pack Size
Tablet 0.3 mg Not specified
Tablet 0.625 mg Blister 28s
Tablet 1.25 mg Blister 28s
Injection (IV) Various Hospital supply

Legal Classification

Premarin is a TGA‑registered prescription medicine in Australia.

PBS listing depends on formulation and indication and may vary by strength; always check the PBS schedule before advising on cost or subsidy.

When PBS subsidy applies, patients require a valid prescription from a GP or specialist and prescribers must document the indication if authority items apply.

E‑prescriptions issued via telehealth are accepted in community pharmacies.

Rural patients often use local community pharmacies or accredited online pharmacies for supply and monitoring.

Remind patients that despite online offers, a prescription is required for systemic oestrogen therapy unless directed otherwise by their prescriber.

Dosing Guide

Standard Regimens

Patients commonly ask, “What dose should I start on?”.

Typical adult dosing for menopausal symptoms ranges from 0.3 mg to 1.25 mg daily, with common starting doses of 0.3 mg or 0.625 mg.

For osteoporosis prevention, 0.625 mg daily is commonly cited where oestrogen is appropriate and other treatments are unsuitable.

Treatment follows the principle of the lowest effective dose for the shortest duration consistent with treatment goals.

Prescribers should document indication and a plan for review when initiating therapy, particularly for PBS‑subsidised items.

Use Starting Dose Maintenance Dose
Vasomotor symptoms 0.3–0.625 mg daily 0.3–1.25 mg daily as needed
Osteoporosis prevention 0.625 mg daily 0.625 mg daily
Hypoestrogenism Individualised 0.3–1.25 mg Individualised

Adjustments For Comorbidities

Lower starting doses are advised for older patients and those with thrombotic or hepatic risk.

Avoid Premarin in severe liver disease and use caution in renal impairment.

Patients with a uterus should have a progestogen added for endometrial protection when using systemic oestrogen.

Monitor blood pressure, lipids and glycaemic control after initiation in patients with hypertension, diabetes or dyslipidaemia.

Assess thrombotic risk factors such as obesity and smoking and document results in the patient record.

Q&A — “What If I Miss A Dose?”

If you miss a dose, take it as soon as you remember unless it is nearly time for your next dose.

Do not double up to make up for missed tablets.

If several consecutive doses are missed, contact your prescriber or pharmacist for advice on restarting and monitoring.

Seek immediate advice if you experience unusual bleeding or severe symptoms after missed or changed dosing.

Interaction Chart

Food And Drinks

Patients frequently ask about alcohol and food while taking Premarin.

Excess alcohol intake increases vascular risk and may worsen mood changes; advise moderation.

No major interactions are established with typical Australian foods, but maintain a stable diet to help monitor weight and fluid retention.

Grapefruit does not have a well‑established interaction with conjugated estrogens, but general caution is reasonable for medicines metabolised by hepatic CYP enzymes.

Common Drug Conflicts

Conjugated estrogens can be affected by enzyme inducers that lower oestrogen levels and may reduce efficacy.

Interacting Drug Effect Monitoring / Action
Carbamazepine, Phenytoin, Rifampicin, St John’s Wort Induce metabolism; may reduce oestrogen effect Consider alternative therapy or monitor symptoms and adjust dose
Warfarin May alter INR Monitor INR closely when starting or stopping Premarin
Corticosteroids, Thyroid Hormones, Some Antidiabetics May require dose review Monitor clinical effect and laboratory markers

User Reports And Trends

What do Australian users say about Premarin?

Feedback on community sites and pharmacy reports commonly highlights relief of hot flushes and night sweats within days to weeks.

Early in therapy some women report irregular vaginal bleeding, breast tenderness and mood shifts which often settle with time or dose adjustment.

Price sensitivity is a frequent theme and many patients ask about PBS subsidy and cheaper generic options.

Rural users often report delays accessing specialists and rely on telehealth and local pharmacists for monitoring and prescription renewals.

  • Pros (User Reports):
  • Effective relief of vasomotor symptoms.
  • Improved sleep and quality of life for many users.
  • Cons (User Reports):
  • Initial spotting or bleeding, breast tenderness.
  • Concerns about long‑term risks and costs.
Complaint Reported Frequency (Community Feedback)
Hot flush relief Common
Vaginal spotting Occasional
Breast tenderness Occasional
Price sensitivity Common

Remember these are anecdotal reports and clinicians should consult published evidence and TGA advisories for clinical decisions.

Access And Purchase Options

National Chains

Premarin is available by prescription and is routinely stocked in major Australian pharmacy chains, though availability varies by pack size.

Chemist Warehouse, Priceline and TerryWhite Chemmart commonly assist with PBS enquiries, price checks and substitution options where generics are listed.

Pharmacists can check TGA and PBS status and help patients obtain the correct strength and pack size.

Online Pharmacies And Telehealth E‑Prescriptions

Accredited Australian online pharmacies will dispense Premarin on receipt of a valid prescription, including e‑prescriptions issued via telehealth.

For rural and remote patients consider postal delivery and liaison with local community health services to arrange monitoring.

Verify identity and prescription authenticity before supply and ensure the product is TGA‑approved.

  • Safe Online Purchase Checklist:
  • Valid prescription from an AHPRA‑registered prescriber.
  • TGA‑approved product supplied.
  • Confirm product strength and pack size.
  • No cold chain required for tablets; verify packaging for heat protection if postal delivery to remote areas.

In our online pharmacy, premarin is available without a prescription, with discreet delivery to Australia in 9‑21 days.

Mechanism And Pharmacology

Simplified Explanation

Patients often want a simple explanation of how Premarin works.

Premarin is a mixture of conjugated oestrogens that act on oestrogen receptors ERα and ERβ to relieve vasomotor symptoms and help preserve bone density.

Systemic oestrogen replacement modifies thermoregulatory centres, improves urogenital tissue trophism and slows bone turnover.

Onset of symptomatic relief for hot flushes can be within days to weeks while bone benefits take months.

Clinical Terms

ATC classification for Premarin is G03CA57, under estrogens for systemic use.

  • Conjugated Estrogens: a mixture of oestrogenic compounds used for systemic HRT.
  • ATC Code: G03CA57.
  • Systemic HRT: hormone therapy that affects the whole body rather than being local only.
  • Oestrogen Receptor: ERα and ERβ are the receptors mediating oestrogen effects.
Target Expected Clinical Outcome
Thermoregulatory centres Reduction in hot flushes and night sweats
Urogenital tissues Improved vaginal dryness and urinary symptoms
Bone turnover Slower bone loss over months

Indications And Off‑Label Uses

Approved Indications By TGA

Premarin is TGA‑registered for relief of menopausal vasomotor and urogenital symptoms and for prevention of osteoporosis where other treatments are unsuitable.

Other approved uses include treatment of hypoestrogenism due to ovarian failure or surgical removal of the ovaries and selected palliative uses in oncology under supervision.

Off‑Label Uses In Australian Clinical Practice

Off‑label use may occur under specialist direction, for example in certain palliative oncology regimens.

Off‑label prescribing should be documented with informed consent and a clear risk–benefit justification.

  • Approved Indications:
  • Menopausal vasomotor and urogenital symptom relief.
  • Prevention of postmenopausal osteoporosis (when appropriate).
  • Hypoestrogenism due to ovarian failure.
  • Off‑Label Uses (Specialist Only):
  • Selected palliative oncology protocols under specialist supervision.
  • Avoid use in children — safety not established.

Always consult local guidelines, the product information and TGA updates before off‑label prescribing.

Key Clinical Findings (2022–2026)

Recent evidence through to 2026 emphasises personalised risk stratification for HRT use.

Major meta‑analyses continue to show systemic oestrogens increase VTE risk and indicate a small increase in stroke risk in older initiators.

Benefits remain clear for vasomotor symptom control and for preservation of bone mineral density when used appropriately.

Clinical practice should include baseline assessment of blood pressure, BMI, smoking, and VTE personal or family history with scheduled review at 3–6 months and annually thereafter.

Study / Source Clinical Takeaway
Contemporary Meta‑Analyses (2022–2026) Increased VTE risk with systemic oestrogens; symptom and bone benefits persist.
TGA / NHMRC Guidance Updates Recommend individualised risk assessment and documentation for HRT initiation.

Clinicians should keep up to date with the TGA and national guidance when counselling and prescribing.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Product Formulation Typical Dose PBS Subsidy Status Pros Cons
Premarin (Conjugated Estrogens) Oral tablets 0.3–1.25 mg daily Varies by indication Effective for vasomotor symptoms and bone Oral first‑pass hepatic effect; VTE risk
Estradiol (Estrace/Estrofem) Oral tablets Individualised Varies Widely available; estradiol is bioidentical Oral hepatic effects similar to other oral oestrogens
Transdermal Patch (Climara) Patch Various patch strengths Varies Lower first‑pass hepatic exposure; possibly lower VTE risk Skin irritation; patch adherence
Vaginal Oestrogen (Ovestin) Local cream/tablet Local dosing Varies Targets local atrophy with minimal systemic exposure Not suitable for systemic vasomotor symptoms

Pros And Cons Checklist

  • Assess symptom profile: vasomotor versus urogenital needs.
  • Check uterus status — add progestogen if uterus present.
  • Evaluate VTE and cardiovascular risk before choosing oral versus transdermal.
  • Discuss cost and PBS subsidy options with the patient.
  • Document shared decision and follow‑up plan in the patient record.

Common Questions (Pharmacy Consultations)

Here are concise answers to frequent patient questions at the pharmacy.

  • Is Premarin on the PBS? PBS listing depends on strength and indication; check the PBS schedule for current subsidy details.
  • Will it affect my risk of breast cancer? Long‑term systemic oestrogen (especially combined HRT) may affect breast cancer risk; discuss individual risk and screening with a GP.
  • How long until relief? Hot flush relief can begin within days to weeks; full bone benefits take months.
  • Can I drink alcohol? Moderate alcohol is advised; heavy drinking increases vascular risk and may worsen mood changes.
  • What if I smoke? Smoking increases VTE and cardiovascular risk; counsel cessation before or during HRT.

Red‑flag symptoms requiring urgent review include chest pain, sudden shortness of breath, sudden severe headache and unilateral leg swelling.

Train pharmacy staff to use a brief screening script at supply and provide TGA or manufacturer patient information leaflets.

Price And Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Pharmacy / Source Typical Out‑Of‑Pocket Price (Non‑PBS) PBS Subsidy Availability Prescription Required Delivery Options
Chemist Warehouse Varies Depends on indication Yes In‑store, click & collect, courier
Priceline Varies Depends Yes In‑store, courier
TerryWhite Chemmart Varies Depends Yes In‑store, courier
Accredited Online Pharmacies Varies Depends Yes Postal delivery
Hospital Supply Not applicable Hospital provision Yes Hospital pharmacy supply

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Confirm valid prescription and strength.
  • Check PBS eligibility and concession card entitlements.
  • Ask about generic alternatives and price differences.
  • Arrange e‑prescription for telehealth consults when needed.
  • Advise rural patients to allow lead time for refills and arrange expedited courier delivery if required.

Registration And Regulation

TGA Approval

Premarin is TGA‑registered; pharmacists and prescribers should check the TGA ARTG entry and product information for current indications and safety updates.

Manufacturers like Pfizer submit product information changes and safety updates through the TGA channels.

PBS Subsidy Details

PBS listing varies by strength and indication and may require authority codes or specific documentation from prescribers.

Prescribers must record the PBS item code and authority where applicable and counsel patients on concession card and Safety Net entitlements.

  • TGA Responsibilities: Evaluate safety, efficacy and approve ARTG entries.
  • PBS Responsibilities: Determine subsidy eligibility, item numbers and authority requirements.

Storage And Handling

Household Storage In Australian Climate

Store Premarin tablets at room temperature between 15–30°C and protect them from moisture and light.

Advise patients to keep tablets in the original blister until use and avoid storing medicines in bathrooms where humidity is high.

During hot Australian summers or travel, remind patients to store tablets in the shade and avoid leaving packs in hot cars.

Keep medicines out of reach of children and pets.

Cold‑Chain Handling For Pharmacies

Premarin tablets do not require a cold chain for transport or storage.

Pharmacies should follow the manufacturer product information for ambient storage and monitor ambient storage areas during heatwaves if local policy requires temperature logs.

  • Store at 15–30°C, protected from moisture and light.
  • Use routine packaging for deliveries; consider expedited post for remote areas to avoid prolonged heat exposure.
  • Advise patients on carrying prescriptions and safe storage during travel.

Guidelines For Proper Use

Australian Pharmacist Counselling Style

Start consultations by asking about the patient’s main concern: hot flushes, vaginal symptoms or bone protection.

Screen contraindications and explain benefits and risks in plain English, including VTE, stroke and potential breast cancer risks.

Discuss alternatives such as transdermal estradiol or local vaginal oestrogens, and cover PBS cost implications.

Use culturally safe communication and involve Aboriginal and Torres Strait Islander health services or community health practitioners when appropriate.

Provide written information including the TGA product information or manufacturer patient leaflet and document the counselling in the patient record.

Patient Advice From PBS And National Health Authorities

Advise baseline checks such as blood pressure, BMI and, where applicable, mammography according to age and risk.

Schedule follow‑up at 3–6 months after initiation and then annually for ongoing review and risk assessment.

Encourage smoking cessation as a priority to reduce VTE and cardiovascular risk while on HRT.

  • Follow‑up checklist: BP, weight/BMI, smoking status, review of symptoms at 3–6 months.
  • Red‑flag symptoms: chest pain, sudden shortness of breath, severe headache, unilateral leg swelling — seek urgent care.

Delivery Across Australia

City Region Delivery time
Sydney New South Wales 9–14 days
Melbourne Victoria 9–14 days
Brisbane Queensland 9–14 days
Perth Western Australia 9–14 days
Adelaide South Australia 9–14 days
Canberra Australian Capital Territory 9–14 days
Hobart Tasmania 9–14 days
Gold Coast Queensland 9–14 days
Newcastle New South Wales 14–21 days
Wollongong New South Wales 14–21 days
Townsville Queensland 14–21 days
Darwin Northern Territory 14–21 days
Ballarat Victoria 14–21 days
Albany Western Australia 14–21 days

Related products